Extracorporeal photopheresis in the treatment of graft-vs-host disease.
Foss
Francine M
FM
Bone Marrow Transplantation and Experimental Therapeutics, Tufts New England Medical Center, Boston, Massachusetts 02111, USA. ffoss@tufts-nemc.org
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000818:Animals; D016026:Bone Marrow Transplantation / Q000276:immunology; D002648:Child; D002986:Clinical Trials as Topic; D003713:Dendritic Cells / Q000276:immunology; D004195:Disease Models, Animal; D004285:Dogs; D005500:Follow-Up Studies; D006086:Graft vs Host Disease / Q000188:drug therapy / Q000401:mortality / Q000517:prevention & control / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D051379:Mice; D015649:Pentostatin / Q000008:administration & dosage; D017893:Photopheresis; D010865:Pilot Projects; D011788:Quality of Life; D012307:Risk Factors; D033581:Stem Cell Transplantation; D013997:Time Factors; D014019:Tissue Donors; D016896:Treatment Outcome; D014916:Whole-Body Irradiation
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D015649:Pentostatin